We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mobile Device Rapidly Detects Zika and Related Viruses

By LabMedica International staff writers
Posted on 31 Mar 2017
Print article
Image: A prototype of the mobile diagnostic device developed by Sandia scientists and engineers for rapid detection of Zika and related viruses (Photo courtesy of Sandia National Laboratories / Randy Wong).
Image: A prototype of the mobile diagnostic device developed by Sandia scientists and engineers for rapid detection of Zika and related viruses (Photo courtesy of Sandia National Laboratories / Randy Wong).
A team of biologists and engineers have developed a smartphone-controlled, battery-operated, low-weight diagnostic technology that costs as little as USD 100 and can detect Zika, dengue, and chikungunya viruses within 30 minutes. The same platform can also be adapted to detect other human or animal pathogens.

Accurate testing for these viruses currently requires a laboratory with expensive instruments, making local testing unrealistic for limited-resource clinics where the viruses are prevalent. The team, from Sandia National Laboratories (Livermore, CA, USA), used smartphone technology as a key feature: “In addition to creating an app that serves as a simple interface to operate the device, we were able to adapt smartphone camera sensors to replace traditional laboratory sample analysis tools, allowing for unprecedented mobility,” said lead author Aashish Priye.

The “laboratory in a box” device is based on the loop-mediated isothermal amplification (LAMP) diagnostic method, which eliminates PCR thermal cycling as well as the need to process the biological sample (e.g. blood or urine) before testing. LAMP copies viral DNA/RNA but without the heating/cooling cycles of PCR, so a heavy-duty power source is not needed. The addition of a few carefully designed biochemical reagents allows a LAMP box to test a sample that is heated only once for 30 minutes.

“We’ve demonstrated that the chemistry we’re using can amplify viral RNA directly from raw, unprocessed samples,” said project lead Robert Meagher, “That is the ideal for a point-of-care testing scenario because you don’t want to have extra equipment for isolating DNA or RNA.” Meagher and team previously developed a method to combine LAMP with an additional detection technique so that multiple viruses could be tested simultaneously. This other technique, named quenching of unincorporated amplification signal reporters (QUASR), involves using synthetic virus-based primers tagged with fluorophores for the sample-DNA/RNA amplification step.

For the Zika project, Meagher’s team developed a novel algorithm that allows a smartphone sensor to act as a fluorimeter, detecting QUASR LAMP light signals if they appear. The user need only place the smartphone on top of the LAMP box and open an app that turns on the heater to initiate the LAMP reaction, after which the smartphone photographs the sample. The app then employs a novel image analysis algorithm to determine the color and brightness of the fluorescence emitted from the LAMP reaction.

Zika, dengue, and chikungunya are spread via the same mosquito vector and have similar early symptoms. The team’s prototype diagnostic tool could enable care providers to test quickly for all three at the same time, preventing misdiagnoses.

The cost of making a LAMP box prototype to test for these viruses depends largely on the cost of the phone selected for using it with. “There are billions of smartphones in the world, even in developing countries, and this tool doesn’t require the highest-end smartphone on the market,” said Priye, “It only needs to have an optical sensor and be able to run the app.” The smartphone used in Sandia’s successful tests of the current prototype costs only USD 20.

The study, by Priye A et al, was published online March 20, 2017, in the journal Scientific Reports.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.